Idhifa Tablet, Film Coated
Product Images NDC 59572-710

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Idhifa (NDC 59572-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Idhifa 01)

Chemical structure of enasidenib mesylate, the active ingredient in Idhifa, shown as a molecular diagram with labeled trifluoromethyl groups (CF3) and a mesylate (CH3SO3H) component.*

FDA Label Image

50 mg Label (Idhifa 02)

Label for Idhifa 50 mg film-coated tablets containing enasidenib mesylate, for oral use. The label states to dispense in original container with desiccant and swallow tablets whole. It also includes storage instructions and manufacturer information for Celgene Corporation. The package contains 30 tablets.*

FDA Label Image

100 mg Label (Idhifa 03)

Label of Idhifa 100 mg (enasidenib) film-coated tablets by Celgene Corporation. The label states to dispense in original container with desiccant and swallow tablets whole. It includes the NDC number 59572-710-30 and indicates a package containing 30 tablets. Storage instructions and manufacturing details are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.